616 results about "Coefficient of variation" patented technology

An aspect of the present invention relates to a magnetic recording medium comprising a nonmagnetic layer containing a nonmagnetic powder and a binder and a magnetic layer containing a ferromagnetic powder and a binder in this order on a nonmagnetic support, whereinthe magnetic layer comprises a nonmagnetic powder of which coefficient of variation CV of a particle size distribution as denoted by the following formula (1):CV(%)=σ / φ×100  (1)is less than 20 percent, andthe magnetic layer has a thickness being equal to or less than 0.1 μm and falling within a range of 1.1≦φ / t≦8.0, wherein σ denotes a standard deviation of a particle diameter, φ denotes an average particle diameter of the nonmagnetic powder comprised in the magnetic layer being expressed in μm, and t denotes a thickness of the magnetic layer being expressed in μm.

The invention provides particle compositions having applications in nucleic acid analysis. Nucleic acid polymer particles of the invention allow polynucleotides to be attached throughout their volumes for higher loading capacities than those achievable solely with surface attachment. In one aspect, nucleic acid polymer particles of the invention comprise polyacrylamide particles with uniform size distributions having low coefficients of variations, which result in reduced particle-to-particle variation in analytical assays. Such particle compositions are used in various amplification reactions to make amplicon libraries from nucleic acid fragment libraries.

The present invention relates a method of preparing agarose beads, which method results in a population of beads which are of relatively uniform particle size. In an advantageous embodiment, the beads are of a particle size less than 10 μm, and the coefficient of variation C.V. of the population is less than 15%. The beads according to the invention are advantageously used in biological separation methods, such as in the production of chromatographic packing materials; drug carriers; or in any method of biological engineering.

An object of the present invention is to provide a sleep state estimation device capable of estimating a sleep state (deep sleep, light sleep) in real time with relative simplicity. Voltage variations resulting from human respiratory movement are measured for each given period to calculate from the measurement results positive voltage peak values and time intervals between adjacent peaks. The obtained peak values and peak intervals are used to calculate a mean peak interval value A, a coefficient of variation B based on dispersion of the peak intervals, and a coefficient of variation C based on the peak values. The sleep state in this period is estimated from the calculation results. More specifically, referring to FIG. 5, the sleep state is estimated as a “wakeful state” or a “hypnagogic state” by checking whether the mean value A is larger or smaller than a threshold a and whether the coefficient of variation C is larger or smaller than a threshold c (S105) whereas the sleep state is estimated as the “hypnagogic state”, “light sleep” or “deep sleep” by checking whether the coefficient of variation B is larger or smaller than a threshold b and whether the coefficient of variation C is larger or smaller than the threshold c (S109, S113, S116, S117).

Provided is a developer for replenishment capable of forming a high-quality image even upon duration. The developer for replenishment includes at least a toner and a magnetic carrier, and in the developer for replenishment, 1 part by mass of the magnetic carrier is blended with 2 to 50 parts by mass of the toner, and the magnetic carrier contains a ferrite core and a resin component, has a true specific gravity of 2.5 to 4.2 g / cm3, has a 50% particle diameter on a volume basis (D50) of 15 to 70 μm, and has an average circularity of 0.850 to 0.950, the average circularity having a coefficient of variation of 1.0 to 10.0%.

A combustor (28) for a gas turbine engine is provided comprising a primary combustion chamber (30) for combusting a first fuel to form a combustion flow stream (50) and a transition piece (32) located downstream from the primary combustion chamber (30). The transition piece (32) comprises a plurality of injectors (66) located around a circumference of the transition piece (32) for injecting a second fuel into the combustion flow stream (50). The injectors (66) are effective to create a radial temperature profile (74) at an exit (58) of the transition piece (32) having a reduced coefficient of variation relative to a radial temperature profile (64) at an inlet (54) of the transition piece (32). Methods for controlling the temperature profile of a secondary injection are also provided.

High resolution B-mode ultrasound images of the common carotid artery are obtained with an ultrasound transducer using a standardized methodology. Subjects are supine with the head counter-rotated 45 degrees using a head pillow. The jugular vein and carotid artery are located and positioned in a vertical stacked orientation. The transducer is rotated 90 degrees around the centerline of the transverse image of the stacked structure to obtain a longitudinal image while maintaining the vessels in a stacked position. A computerized methodology assists operators to accurately replicate images obtained over several spaced-apart examinations. The methodology utilizes a split-screen display in which the arterial ultrasound image from an earlier examination is displayed on one side of the screen while a real-time “live” ultrasound image from a current examination is displayed next to the earlier image on the opposite side of the screen. By viewing both images, whether simultaneously or alternately, while manually adjusting the ultrasound transducer, an operator is able to bring into view the real-time image that best matches a selected image from the earlier ultrasound examination. Utilizing this methodology, measurement of vascular dimensions such as carotid arterial IMT and diameter, the coefficient of variation is substantially reduced to values approximating from about 1.0% to about 1.25%. All images contain anatomical landmarks for reproducing probe angulation, including visualization of the carotid bulb, stacking of the jugular vein above the carotid artery, and initial instrumentation settings, used at a baseline measurement are maintained during all follow-up examinations.

The invention provides particle compositions having applications in nucleic acid analysis. Nucleic acid polymer particles of the invention allow polynucleotides to be attached throughout their volumes for higher loading capacities than those achievable solely with surface attachment. In one aspect, nucleic acid polymer particles of the invention comprise polyacrylamide particles with uniform size distributions having low coefficients of variations, which result in reduced particle-to-particle variation in analytical assays. Such particle compositions are used in various amplification reactions to make amplicon libraries from nucleic acid fragment libraries.